Akanocure COVID-19 Treatment Strategy (image)

Purdue University

Caption

Akanocure Pharmaceuticals Inc., a Purdue University-affiliated startup, is receiving national support to pursue a strategy to treat severe COVID-19 cases and possible future outbreaks involving other viruses.

Credit

Chris Adam/Purdue University

Usage Restrictions

None

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.